Efficacy and Adverse Events of Carboplatin Desensitisation Therapy for Gynaecological Cancer: A Retrospective Study

Efficacy and Adverse Events of Carboplatin Desensitisation Therapy for Gynaecological Cancer: A Retrospective Study

Background: Carboplatin, the key drug used in treating gynaecological cancer, has an approximately 12–16% risk of hypersensitivity reactions. We aimed to investigate the efficacy and adverse effects of carboplatin desensitisation therapy for gynaecological cancer. Methods: The desensitisation protoc...

Full description

Bibliographic Details
Main Authors: Akihito Yamamoto, Seiryu Kamoi, Shigeru Matsuda, Rieko Kawase, Kazuho Nakanishi, Shunji Suzuki
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Medicines
Subjects:
carboplatin
desensitisation
hypersensitivity
malignancy
gynaecology
therapeutic effects
Online Access:https://www.mdpi.com/2305-6320/9/4/26

Internet

https://www.mdpi.com/2305-6320/9/4/26

Similar Items